EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer (Q40093033)

From Wikidata
Jump to navigation Jump to search
scientific article published on 9 May 2008
edit
Language Label Description Also known as
English
EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer
scientific article published on 9 May 2008

    Statements

    EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer (English)
    0 references
    0 references
    Rob Glynne-Jones
    Alec C McDonald
    National Cancer Research Institute Anal Sub Group and Colorectal Clinical Oncology Group

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit